We serve Chemical Name:3-ethyl-2-methylpent-2-ene CAS:19780-67-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-ethyl-2-methylpent-2-ene
CAS.NO:19780-67-7
Synonyms:3-Ethyl-2-methyl-2-pentene;2-Pentene,3-ethyl-2-methyl;3-Aethyl-2-methyl-pent-2-en;3-ethyl-2-methyl-pent-2-ene;1.1-Dimethyl-2.2-diaethyl-aethylen;3-Isopropyliden-pentan;2-Methyl-3-ethyl-2-pentene
Molecular Formula:C8H16
Molecular Weight:112.21300
HS Code:2901299090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:117ºC at 760mmHg
Density:0.729g/cm3
Index of Refraction:1.419
PSA:
Exact Mass:112.12500
LogP:3.14280
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Ethyl-2-methyl-2-pentene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Methyl-3-ethyl-2-pentene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Aethyl-2-methyl-pent-2-en Use and application,2-Pentene,3-ethyl-2-methyl technical grade,usp/ep/jp grade.
Related News: Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder. [(Z)-2-(4-Methoxy-benzyloxy)-1-methyl-vinyloxy]-trimethyl-silane manufacturers Mene Pangalos, executive vice president, BioPharmaceuticals R&D, said: “The data being presented at EULAR add to the growing body of evidence for anifrolumab that demonstrate a compelling clinical profile with the potential to address significant unmet medical needs in this debilitating disease. 2-(4-Nitro-phenyl)-N-(octahydro-naphthalen-4a-yl)-acetamide suppliers UK-headquartered Verona announced at the beginning of the year that it had completed enrolment in a pilot study evaluating the efficacy of ensifentrine delivered via pressurised metered-dose inhaler (pMDI) formulation in patients hospitalised with COVID-19. 6-Heptyn-2-ol, 1-[(1,1-dimethylethyl)sulfinyl]- vendor & factory.
